{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:25:28Z","timestamp":1792686328132,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.jceh.2012.06.004","type":"journal-article","created":{"date-parts":[[2012,9,21]],"date-time":"2012-09-21T03:24:43Z","timestamp":1348197883000},"page":"211-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Hemochromatosis Gene Mutations: Prevalence and Effects on Pegylated-Interferon and Ribavirin Therapy Response in Chronic Hepatitis C in Sardinia"],"prefix":"10.1016","volume":"2","author":[{"given":"Margherita","family":"Sini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orazio","family":"Sorbello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Civolani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Demelia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2012.06.004_bib1","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1182\/blood.V84.6.1697.1697","article-title":"Regulators of iron balance in humans","volume":"84","author":"Finch","year":"1994","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jceh.2012.06.004_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2007-1007214","article-title":"Metal-induced hepatotoxicity","volume":"16","author":"Britton","year":"1996","journal-title":"Semin Liver Dis"},{"issue":"3","key":"10.1016\/j.jceh.2012.06.004_bib3","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0168-8278(05)80671-3","article-title":"Liver damage in Italian patients with hereditary hemochromatosis is highly influenced by hepatitis B and C virus infection","volume":"16","author":"Piperno","year":"1992","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2012.06.004_bib4","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0168-8278(97)80265-6","article-title":"The haemochromatosis gene","volume":"26","author":"Riedel","year":"1997","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.jceh.2012.06.004_bib5","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/gut.51.5.723","article-title":"Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls","volume":"51","author":"Holmstrom","year":"2002","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.jceh.2012.06.004_bib6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/10906570050114902","article-title":"Geography of HFE C282Y and H63D mutations","volume":"4","author":"Merryweather-Clarke","year":"2000","journal-title":"Genet Test"},{"issue":"3","key":"10.1016\/j.jceh.2012.06.004_bib7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1006\/bcmd.2002.0567","article-title":"Frequency of the HFE gene mutations in five Italian populations","volume":"29","author":"Candore","year":"2002","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.jceh.2012.06.004_bib8","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1002\/hep.510270631","article-title":"Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C","volume":"27","author":"Smith","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2012.06.004_bib9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0016-5085(99)70236-2","article-title":"The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C","volume":"116","author":"Kazemi-Shirazi","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2012.06.004_bib10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000040991","article-title":"Are haemochromatosis mutations related to the severity of liver disease in hepatitis C virus infection?","volume":"102","author":"Martinelli","year":"2000","journal-title":"Acta Haematol"},{"key":"10.1016\/j.jceh.2012.06.004_bib11","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJM199612123352403","article-title":"Clinical and biochemical abnormalities in people heterozygous for hemochromatosis","volume":"335","author":"Bulaj","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2012.06.004_bib12","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/0016-5085(92)90339-Z","article-title":"Measurements of iron status in patients with chronic hepatitis","volume":"102","author":"Di Bisceglie","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2012.06.004_bib13","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0168-8278(94)80017-0","article-title":"Response to interferon alfa therapy is influenced by the iron content of the liver","volume":"20","author":"Van thiel","year":"1994","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2012.06.004_bib14","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0168-8278(95)80108-1","article-title":"Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis","volume":"22","author":"Farinati","year":"1995","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2012.06.004_bib15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1053\/gast.2003.50046","article-title":"Hepatitis C, iron status and disease severity: relationship with HFE mutations","volume":"124","author":"Tung","year":"2003","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.jceh.2012.06.004_bib16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1478-3231.2004.0928.x","article-title":"Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C","volume":"24","author":"Geier","year":"2004","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.jceh.2012.06.004_bib17","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1034\/j.1600-0676.2000.020006482.x","article-title":"Heterozygosity for hemochromatosis gene in liver diseases: prevalence and effects on liver histology","volume":"20","author":"Hohler","year":"2000","journal-title":"Liver"},{"key":"10.1016\/j.jceh.2012.06.004_bib18","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/0016-5085(95)90209-0","article-title":"Hepatic iron concentration as a predictor of response to interferon alpha therapy in chronic hepatitis C","volume":"108","author":"Olynyc","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2012.06.004_bib19","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/hep.1840190538","article-title":"A\u00a0proposed system for the nomenclature of hepatitis C viral genotypes (letter)","volume":"19","author":"Simmonds","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2012.06.004_bib20","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/hep.1840190629","article-title":"Classification of chronic hepatitis: diagnosis, grading and staging","volume":"19","author":"Desmet","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2012.06.004_bib21","first-page":"396","article-title":"Evaluation of iron status in patients with chronic hepatitis C","volume":"30","author":"Sartori","year":"1998","journal-title":"Ital J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2012.06.004_bib22","first-page":"220","article-title":"Role of iron load on fibrogenesis in chronic hepatitis C","volume":"47","author":"Casaril","year":"2000","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jceh.2012.06.004_bib23","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/hep.510290623","article-title":"Effects of iron loading on pathogenicity in hepatitis C virus-infected chimpanzees","volume":"29","author":"Bassett","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2012.06.004_bib24","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0168-8278(02)00018-1","article-title":"Accelerated hepatic fibrosis in patients with combined hereditary hemochromatosis and chronic hepatitis C infection","volume":"36","author":"Diwaakaran","year":"2002","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2012.06.004_bib25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0168-8278(98)80368-1","article-title":"Iron, oxidative stress and liver fibrogenesis","volume":"28","author":"Pietrangelo","year":"1998","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.jceh.2012.06.004_bib26","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0168-8278(02)00415-4","article-title":"HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent factors for liver fibrosis and cirrhosis","volume":"38","author":"Erhardt","year":"2003","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2012.06.004_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/hep.510280427","article-title":"Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations","volume":"28","author":"Piperno","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2012.06.004_bib28","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1111\/j.1572-0241.2002.05753.x","article-title":"HFE mutations prevent sustained virological response to interferon plus ribavirin in chronic hepatitis C patients with serum markers of iron overload","volume":"97","author":"Coelho-Borges","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2012.06.004_bib29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0140-6736(02)07447-0","article-title":"Penetrance of 845G*A (C282Y) HFE hereditary haemochromatosis mutation in the USA","volume":"359","author":"Beutler","year":"2002","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jceh.2012.06.004_bib30","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0016-5085(98)70319-1","article-title":"Heterogeneity of hemochromatosis in Italy","volume":"114","author":"Piperno","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2012.06.004_bib31","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/hep.1840010206","article-title":"HLA typing in idiopathic hemochromatosis: distinction between homozygotes and heterozygotes with biochemical expression","volume":"1","author":"Bassett","year":"1981","journal-title":"Hepatology"},{"issue":"35","key":"10.1016\/j.jceh.2012.06.004_bib32","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.3748\/wjg.v13.i35.4673","article-title":"HFE gene in primary and secondary hepatic iron overload","volume":"13","author":"Sebastiani","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.jceh.2012.06.004_bib33","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1053\/jhep.2001.24783","article-title":"AASLD practice guidelines diagnosis and management of hemochromatosis","volume":"33","author":"Tavill","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2012.06.004_bib34","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1056\/NEJM199909023411002","article-title":"A\u00a0population based study of the clinical expression of the hemochromatosis gene","volume":"341","author":"Olynyk","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2012.06.004_bib35","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0168-8278(02)00305-7","article-title":"Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C","volume":"37","author":"Bonkovsky","year":"2002","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2012.06.004_bib36","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/BF02091542","article-title":"Hepatic iron contents and response to interferon alfa in patients with chronic hepatitis C relationship to genotypes of hepatitis C virus","volume":"41","author":"Izumi","year":"1996","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2012.06.004_bib37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1053\/jhep.2000.8700","article-title":"Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial","volume":"32","author":"Di Bisceglie","year":"2000","journal-title":"Hepatology"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S097368831200031X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S097368831200031X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:00:55Z","timestamp":1760853655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S097368831200031X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S097368831200031X"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2012.06.004","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hemochromatosis Gene Mutations: Prevalence and Effects on Pegylated-Interferon and Ribavirin Therapy Response in Chronic Hepatitis C in Sardinia","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2012.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 INASL. Published by Elsevier, a division of Reed Elsevier India, Pvt. Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}